|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for bad debt of $21,345 for the years ended December 31, 2016 and 2015 | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Inventory, net of inventory reserves of $465,196 and $540,037 for the years ended December 31, 2016 and 2015 | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Net | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Liabilities and stockholders' equity (deficit) | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Convertible bridge notes | ||||||||||||||||||||
| Accrued interest convertible notes | ||||||||||||||||||||
| Derivative conversion feature senior convertible notes | ||||||||||||||||||||
| Subordinated convertible notes | ||||||||||||||||||||
| Senior convertible notes, net of discount | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Senior convertible notes, net of discount of $0 and $2,277,712 as of December 31, 2016 and 2015 | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Note payable | ||||||||||||||||||||
| Derivative liability senior warrants | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Convertible preferred stock-12,500,000 shares authorized Series A preferred - 2,000,000 shares designated, $0.005 par value, 0 shares issued and outstanding | ||||||||||||||||||||
| Series Preferred Stock | ||||||||||||||||||||
| Total convertible preferred stock-12,500,000 shares authorized Series A preferred - 2,000,000 shares designated, $0.005 par value, 0 shares issued and outstanding | ||||||||||||||||||||
| Common stock - 100,000,000 shares authorized $0.005 par value, 95,954,549 issued and outstanding (9,920 in 2015) | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Cumulative foreign currency translation adjustment | ||||||||||||||||||||
| Other comprehensive income | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
